Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07265206 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is a single-arm, open-label, non-randomized clinical trial aimed at evaluating the safety, tolerability and preliminary efficacy of HY001N cell injection in the treatment of patients with relapsed/refractory Neurological Autoimmune Diseases.
Trial Details
NCT Number NCT07265206
Lead Sponsor Juventas Cell Therapy Ltd.
Collaborators: Beijing Tiantan Hospital
Conditions
(from sponsor)		 Neurological Autoimmune Diseases
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov